Remy Sukhija

MDGL

Remy Sukhija serves as Chief Commercial Officer at Madrigal Pharmaceuticals, Inc. (MDGL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$8.22M

Net Position

Net Seller

$8.22M

Companies Traded

MDGL

Active Period

Dec 2022

1 total trades

Most Recent

Sell MDGL

Dec 28, 2022 · $8.22M

Remy Sukhija's Insider Trading at Madrigal Pharmaceuticals, Inc. (MDGL)

Buys

0 · $0.00

Sells

1 · $8.22M

Total Shares Bought

Total Shares Sold

30,000

MDGL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 28, 2022	Sell	30,000	$274.14	$8.22M	29,407

Related Insiders

David Soergel

officer: Chief Medical Officer

MDGLSell · Jun 1, 2026

Richard S Levy

director

MDGLSell · May 22, 2026

Carole Huntsman

officer: Chief Commercial Officer

MDGLSell · Mar 6, 2026

Shannon T Kelley

officer: General Counsel

MDGLSell · Mar 6, 2026

William John Sibold

President and CEO

MDGLSell · Mar 6, 2026

Rebecca Taub

Director

MDGLSell · Mar 6, 2026

Mardi Dier

officer: EVP and CFO

MDGLSell · Mar 6, 2026

FRIEDMAN PAUL A

Director

MDGLSell · Jan 13, 2026

Explore More Insider Trading Data

MDGL Insider Trading Activity

View all insider trades at Madrigal Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity